Author

Chunxiao Zhou

Universitätsklinikum AachenORCID 0000-0002-1257-9537Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Chunxiao Zhou1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alessandro MottaiD· 1 shared Alessia Nucci· 1 shared Alexandros Marios SofiasiD· 1 shared Ananya BhattacharjeeiD· 1 shared Bärbel Junge· 1 shared Cristina Baquero López· 1 shared Emiel P. C. van der VorstiD· 1 shared Fabian M. KiesslingiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessandro MottaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Melatonin nanoparticles inhibit mutant hematopoiesis and restore bone marrow architecture in myeloproliferative neoplasms

Siddharth Gupta, Alessandro Motta, Sara Elsafy, Shiva Khorshid, Alessia Nucci, Vishrutha Sampath, Ananya Bhattacharjee, Margherita Vieri, Kathrin Olschok, Kristina Pannen, Jelena Lazarevic, Maria Jimena Rodriguez, Patrick Weiand, Venkatakrishnan Hariharan, Cristina Baquero López, , Nicolas Chatain

This study shows that melatonin nanoparticles reduce myeloproliferative neoplasm symptoms by targeting metabolic, inflammatory, and fibrotic pathways.

bioRxiv · Aug 31, 2026 · PreprintCancer Biology